NeuroBo Pharmaceuticals, Inc. (NRBO) SEC filings

NRBO SEC filings moved a median of -1.30% by the close. NRBO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NRBO overview →

65 measured NRBO SEC filing events.

Where these NRBO SEC filings landedvs 49 measured NRBO SEC filing reactions
NRBO SEC filingMiddle 50% · -3.56% to +3.02%Zero: 0.00%Median: -1.30%Median -1.30%-5.00%0+5.00%
Middle 50% of NRBO SEC filing reactions-3.56% to +3.02%
Median reaction (to close)-1.30%
Measured reactions49
Point-in-time · zero look-ahead

Half of the 49 NRBO SEC filing events with a measured close landed between -3.56% and +3.02%; 41% closed up.

DateHeadlineEvent5-minTo close
Form 8-K MetaVia Inc. For: May 21SEC filing · Form 8-K——
Form D MetaVia Inc.SEC filing · Form D——
Form 10-Q MetaVia Inc. For: Mar 31SEC filing · Form 10-Q——
Form 8-K MetaVia Inc. For: May 08SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: May 14SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: May 07SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: Apr 22SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: Apr 15SEC filing · Form 8-K——
Form EFFECT MetaVia Inc.SEC filing · Form EFFECT——
Form POS AM MetaVia Inc.SEC filing · Form POS——
Form S-8 MetaVia Inc.SEC filing · Form S-8——
Form 10-K MetaVia Inc. For: Dec 31SEC filing · Form 10-K——
Form 8-K MetaVia Inc. For: Mar 20SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: Jan 10SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: Dec 18SEC filing · Form 8-K——
Form 8-K MetaVia Inc. For: Nov 29SEC filing · Form 8-K——
Form 8-K NeuroBo Pharmaceuticals, For: Nov 15SEC filing · Form 8-K+7.03%+4.05%
Form 10-Q NeuroBo Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+1.85%+3.70%
Form 8-K NeuroBo Pharmaceuticals, For: Nov 07SEC filing · Form 8-K+0.00%+4.28%
Form 8-K NeuroBo Pharmaceuticals, For: Nov 04SEC filing · Form 8-K+7.20%+1.20%
Form 8-K NeuroBo Pharmaceuticals, For: Oct 07SEC filing · Form 8-K+0.70%+1.89%
Form 8-K NeuroBo Pharmaceuticals, For: Sep 30SEC filing · Form 8-K-1.74%-8.12%
Form 8-K NeuroBo Pharmaceuticals, For: Sep 18SEC filing · Form 8-K+0.61%-3.33%
Form DEF 14A NeuroBo Pharmaceuticals, For: Sep 18SEC filing · Form DEF—-1.62%
Form 10-Q NeuroBo Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+3.98%+3.45%
Form 8-K NeuroBo Pharmaceuticals, For: Aug 14SEC filing · Form 8-K+3.27%+6.27%
Form 8-K NeuroBo Pharmaceuticals, For: Aug 13SEC filing · Form 8-K-7.05%-1.30%
Form PRE 14A NeuroBo Pharmaceuticals, For: Sep 18SEC filing · Form PRE—+0.53%
Form 8-K NeuroBo Pharmaceuticals, For: Aug 06SEC filing · Form 8-K-1.88%+3.02%
Form 8-K NeuroBo Pharmaceuticals, For: Jul 30SEC filing · Form 8-K+0.00%-3.07%
Form EFFECT NeuroBo Pharmaceuticals,SEC filing · Form EFFECT+0.48%-0.61%
Form S-1 NeuroBo Pharmaceuticals,SEC filing · Form S-1—-5.25%
Form 8-K NeuroBo Pharmaceuticals, For: Jul 16SEC filing · Form 8-K+0.00%-4.17%
Form D NeuroBo Pharmaceuticals,SEC filing · Form D-3.17%-1.06%
Form 8-K NeuroBo Pharmaceuticals, For: Jun 26SEC filing · Form 8-K+5.43%-0.41%
Form 8-K NeuroBo Pharmaceuticals, For: Jun 23SEC filing · Form 8-K+0.00%+3.65%
Form 8-K NeuroBo Pharmaceuticals, For: Jun 24SEC filing · Form 8-K+3.31%+22.89%
Form 8-K NeuroBo Pharmaceuticals, For: Jun 07SEC filing · Form 8-K+5.26%+2.63%
Form 8-K NeuroBo Pharmaceuticals, For: May 22SEC filing · Form 8-K-2.22%-3.56%
Form 10-Q NeuroBo Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q+0.00%+2.96%
Form 8-K NeuroBo Pharmaceuticals, For: May 09SEC filing · Form 8-K+0.00%+2.96%
Form 8-K NeuroBo Pharmaceuticals, For: Apr 30SEC filing · Form 8-K+0.00%-3.56%
Form ARS NeuroBo Pharmaceuticals, For: Dec 31SEC filing · Form ARS+0.00%-3.56%
Form DEF 14A NeuroBo Pharmaceuticals, For: Jun 07SEC filing · Form DEF+0.00%-3.56%
Form EFFECT NeuroBo Pharmaceuticals,SEC filing · Form EFFECT+10.03%+3.68%
Form 8-K NeuroBo Pharmaceuticals, For: Apr 17SEC filing · Form 8-K+0.00%-6.23%
Form 8-K NeuroBo Pharmaceuticals, For: Apr 16SEC filing · Form 8-K+0.00%-6.23%
Form S-3 NeuroBo Pharmaceuticals,SEC filing · Form S-3+0.00%-2.22%
Form 8-K NeuroBo Pharmaceuticals, For: Apr 01SEC filing · Form 8-K+5.10%-1.46%
Form 10-K NeuroBo Pharmaceuticals, For: Dec 31SEC filing · Form 10-K+5.10%-1.46%
Form 8-K NeuroBo Pharmaceuticals, For: Mar 28SEC filing · Form 8-K+0.00%-3.54%
Form 8-K NeuroBo Pharmaceuticals, For: Mar 13SEC filing · Form 8-K-1.17%-10.42%
Form 8-K NeuroBo Pharmaceuticals, For: Mar 04SEC filing · Form 8-K+0.66%+7.59%
Form 8-K NeuroBo Pharmaceuticals, For: Feb 29SEC filing · Form 8-K+3.33%+7.22%
Form 8-K NeuroBo Pharmaceuticals, For: Feb 14SEC filing · Form 8-K-3.64%-3.44%
Form 8-K NeuroBo Pharmaceuticals, For: Feb 01SEC filing · Form 8-K+15.40%+38.13%
Form 8-K NeuroBo Pharmaceuticals, For: Jan 18SEC filing · Form 8-K+0.00%+0.88%
Form 8-K NeuroBo Pharmaceuticals, For: Jan 08SEC filing · Form 8-K-1.11%-1.66%
Form 8-K NeuroBo Pharmaceuticals, For: Dec 28SEC filing · Form 8-K+7.51%+20.14%
Form 8-K NeuroBo Pharmaceuticals, For: Dec 19SEC filing · Form 8-K-0.64%-22.02%
Form 8-K NeuroBo Pharmaceuticals, For: Dec 07SEC filing · Form 8-K-6.72%-5.04%
Form 10-Q NeuroBo Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q-4.42%-4.33%
Form 8-K NeuroBo Pharmaceuticals, For: Nov 13SEC filing · Form 8-K-4.42%-4.33%
Form 8-K NeuroBo Pharmaceuticals, For: Nov 01SEC filing · Form 8-K-4.54%-3.61%
Form 8-K NeuroBo Pharmaceuticals, For: Oct 25SEC filing · Form 8-K+0.00%-0.16%
That’s how NRBO usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More NRBO: earnings → · analyst actions → · NRBO overview →